Solid Neoplasm clinical trials

Explore recruiting solid neoplasm clinical trials.

Recruiting solid neoplasm studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Solid Neoplasm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors

Poland, France, Austria, Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Single microdose trial - CXCR4 PET tracer - Pharmacokinetics and pharmacodynamics of [68Ga]Ga-R54, a CXCR4-targeted radiopharmaceutical in patients with advanced solid tumors.

Italy

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Solid Neoplasm trials by city

Solid Neoplasm in Toronto Solid Neoplasm in Vancouver Solid Neoplasm in Montreal Solid Neoplasm in Calgary Solid Neoplasm in Edmonton Solid Neoplasm in Ottawa Solid Neoplasm in Winnipeg Solid Neoplasm in Quebec City Solid Neoplasm in Hamilton Solid Neoplasm in Kitchener Solid Neoplasm in London Solid Neoplasm in Halifax Solid Neoplasm in New York Solid Neoplasm in Los Angeles Solid Neoplasm in Chicago Solid Neoplasm in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease